Physical Activity and Motivation in Colorectal Cancer Patients

Sponsor
Universidad Miguel Hernandez de Elche (Other)
Overall Status
Recruiting
CT.gov ID
NCT04506840
Collaborator
Puerta de Hierro University Hospital (Other), Ministerio de Ciencia e Innovación, Spain (Other)
34
2
2
41.3
17
0.4

Study Details

Study Description

Brief Summary

The intervention will be a physical exercise program for colorectal cancer patients during the adjuvant chemotherapy. The exercise program aims on reducing the side effects of the treatment and improving patients' quality of life. In addition, the investigators try to improve endurance and resistance training level, in order to achieve greater physical functionality, survival and general well-being. For this, the investigators will carry out an exercise program based mainly on muscular strength and cardiorespiratory condition. It will last 6 months, with a frequency of 3 days per week, including sessions of 60 minutes. Sessions will consist of three parts: warm-up, main part (endurance and resistance training), and cool down. An individualized and supervised progression of training will take place. The intensity levels will always be adjusted to the initial levels of the participants, always considering their preferences and comfort.

Participants' preferences and exercise history will be considered through an initial interview. Motivational strategies based on self-determination theory will be applied, since it is one of the most used theories in the field of physical exercise. This theory proposes that all people need to feel competent, autonomous and socially related. If these three needs are satisfied, participants will develop more positive (autonomous) forms of motivation, which are related to better consequences such as vitality, enjoyment, quality of life and adherence to physical activity. In addition, motivational strategies will be applied for families and healthcare professionals.

Before starting the program and at the end of it, each eligible patient will be evaluated through:

  • Physical activity: strength test of lower and upper limbs, agility test, stress test for cardiorespiratory fitness, physical activity levels, physical condition and body composition.

  • Psychological factors: autonomy support, basic psychological need satisfaction, motivation, quality of life, perceived barriers, depression, anxiety, hope, quality of life.

  • Clinical parameters: survival rate, side effects, biological factors, treatment delays and planned treatment completion.

Condition or Disease Intervention/Treatment Phase
  • Other: Physical activity
N/A

Detailed Description

Objectives and justification of the project In Spain, cancer is the second cause of death after cardiovascular diseases. However, if it is divided by sex, cancer is the leading cause of death for men and the second cause for women. In recent years there has been an increase in new cases of cancer due to population growth and aging, since 2/3 of cancer patients are older than 65 years. In addition to the impact of this disease on people's quality of life, a high economic cost has been estimated for the health system. For example, the total cost of cancer in 2015 in Spain was 7,168 million euros. This situation represents an important public health problem and therefore implies that research on the factors that can prevent or alleviate this disease should be considered as a priority.

In this regard, there is increasing scientific evidence of the physical and psychosocial benefits of exercise both during and after the treatment of this disease. Nevertheless, only 30-40% of cancer survivors perform the necessary physical activity (PA) recommended by the main medical institutions. In fact, a significant number of patients are obese (33%) and have a low cardiorespiratory condition (45%). Despite this, PA continues to decrease after diagnosis and only 5-10% of patients are physically active during treatment and 20-30% after treatment. Therefore, the development of intervention programs aimed at promoting PA should be a fundamental objective in the fight against cancer and its physical and psychosocial consequences. In this line, our general objective will be to develop a motivation PA program for colorectal cancer patients. Specifically, and considering the gaps existing in the current literature, our general objective is subdivided into the following specific objectives:

  • To evaluate the physical, psychosocial and behavioural effects, in the short and medium term, of a physical exercise program in which motivational strategies based on self-determination theory are applied.

  • To explore qualitatively the benefits of the physical exercise program, as well as the troubles encountered in its implementation.

  • To develop an educational guide and an intervention protocol to encourage motivation and adherence to PA of colorectal cancer patients.

Methodology This study will require a sample size of 34 patients. This calculation was made through the G*power software, by means of an analysis of variance (ANOVA), adjusting the values to p <.05, with a statistical power of 80% and an effect size of 0.5. The patients will be recently diagnosed with colorectal cancer in phases II-III by the oncology service of the Hospital Universitario Puerta de Hierro de Majadahonda. Inclusion criteria include to be between 18 and 75 years old, to be undergoing chemotherapy treatment, and to not have any type of associated pathology that prevents them from performing PA. A intervention with an experimental group and a control group will be conducted, where 17 patients will be assigned to a control group, and 17 patients will perform a supervised motivational exercise program.

Measures Cardiorespiratory fitness. Stress tests adapted to the characteristics of the patients will be performed, both in the type of ergometer and in the protocol. We will use electrocardiographic recording and gas exchange analysis. Aerobic and anaerobic exercise thresholds will be established.

Quality of life. The validated Spanish version of the EORTC-QLQ-CR30 will be used for patients with colorectal cancer.

Body composition. Anthropometries will be carried out to estimate body composition parameters.

Biological parameters. The usual analytics carried out in the hospital during the treatment will be used to check the patient's health status and the side effects of the chemotherapy treatment.

Anxiety. The validated version in Spanish of the Hamilton Anxiety Scale will be used.

Depression. The Spanish version of the Hamilton Depression Scale will be used. Autonomy support. The Spanish version of the Perceived Autonomy Support for Exercise Settings will be used.

Perceived barriers to do PA. This scale will be translated and validated to the Spanish context.

Basic psychological needs in exercise. We will use the Basic Psychological Needs in Exercise Scale.

Basic psychological needs in life. The Spanish version of the Basic Psychological Need Satisfaction and Frustration Scale will be used.

Types of motivation. To measure motivation towards PA, the Behavioural Regulation in Exercise Questionnaire will be for PA levels. The Spanish version of the IPAQ questionnaire will be used. On the other hand, PA will be measured in a direct and objective way through portable GT3X accelerometers.

Design, procedure and data analysis The intervention program will be carried out at the Hospital Universitario Puerta de Hierro of Majadahonda. The program will last 6 months, with three weekly one-hour sessions, and will comply with the recommendations established by the American Cancer Society and the American College of Sports Medicine. The safety precautions and contraindications identified by these institutions for colorectal cancer patients will be especially considered. The program will include aerobic sessions at moderate and vigorous intensities, as well as strength work. Patients will be monitored to model exercise loads individually.

The measurements will be made just before starting the PA program (T1) in the case of the experimental group, at an initial time of the equivalent treatment in the case of the control group. The same measures will be carried out 6 months later (T2). For PA levels, instead of measuring them just after the end of the program, we will wait another month so that patients have been able to recover their usual PA levels after the shock that can mean for them to face the end of our program. In the control group, PA levels will also be evaluated one month after T2. To test the effects of the program, all measurements will be performed 6 months after T2 in both groups (T3).

Additionally, qualitative methodology will be used, so that the 17 patients of the experimental group will be interviewed to know the factors related to their adherence to the PA program and the benefits perceived by them with their participation. Qualitative data collection will be reinforced with field notes compiled in research diaries by observers who will be present during the development of the program. Relatives and health professionals will also be interviewed to learn their perspective regarding the benefits of the program and adherence to it in these patients.

In order to promote adherence to the program and to educate in autonomous PA habits when it ends, motivational strategies based on the self-determination theory will be used. Specific strategies will be developed for this group, based on previous works and educational guides for colorectal cancer patients. The instructor in charge of directing the program will be trained in several sessions to use motivational strategies based on this theory. Once the program is finished, an educational guide of motivational strategies for the promotion of PA in patients with colorectal cancer will be developed and published from the perspective of self-determination theory.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
34 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Development of an Educational and Motivational Program to Promote Adherence to Physical Activity and Its Positive Effects in Colorectal Cancer Patients
Actual Study Start Date :
Jan 21, 2020
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training group

Participants will participate in a program of physical exercise during the adjuvant chemotherapy treatment

Other: Physical activity
Patients will participate in a program of physical exercise. Resistance training, endurance training, balance and flexibility will be trained with the objective to reduce the side effects of chemotherapy and, in order to improve their quality of life

No Intervention: Not training group

Participants will not do any intervention, they only will be perform the pre and post-tests.

Outcome Measures

Primary Outcome Measures

  1. Cardiorespiratory fitness [Pre intervention]

    Rockport 1-mile walking test

  2. Cardiorespiratory fitness [In the middle of the intervention (at 3 months)]

    Rockport 1-mile walking test

  3. Cardiorespiratory fitness [At 6 months after the start of the intervention]

    Rockport 1-mile walking test

  4. Cardiorespiratory fitness [One year after the start of the intervention]

    Rockport 1-mile walking test

  5. Strength [Pre intervention]

    Handgrip strength is a measure of the maximum static force that a hand can squeeze using a dynamometer

  6. Strength [In the middle of the intervention (at 3 months)]

    Handgrip strength is a measure of the maximum static force that a hand can squeeze using a dynamometer

  7. Strength [At 6 months after the start of the intervention]

    Handgrip strength is a measure of the maximum static force that a hand can squeeze using a dynamometer

  8. Strength [One year after the start of the intervention]

    Handgrip strength is a measure of the maximum static force that a hand can squeeze using a dynamometer

Secondary Outcome Measures

  1. Quality of life (physical function, emotional role, social function, cognitive function and symptoms such a fatigue, anorexia, dyspnea, etc) [Pre intervention]

    Questionnaire of EORT-QLQ-29 values are assigned between 1 and 4 (1: not at all, 2: a little, 3: quite a bit, 4: a lot) according to the patient's responses to the item, only items 29 and 30 are evaluated with a score of 1 to 7 (1: lousy, 7: excellent). The scores obtained are standardized and a score between 0 and 100 is obtained, which determines the level of impact of the cancer on the patient on each of the scales

  2. Quality of life (physical function, emotional role, social function, cognitive function and symptoms such a fatigue, anorexia, dyspnea, etc) [In the middle of the intervention (at 3 months)]

    Questionnaire of EORT-QLQ-29 values are assigned between 1 and 4 (1: not at all, 2: a little, 3: quite a bit, 4: a lot) according to the patient's responses to the item, only items 29 and 30 are evaluated with a score of 1 to 7 (1: lousy, 7: excellent). The scores obtained are standardized and a score between 0 and 100 is obtained, which determines the level of impact of the cancer on the patient on each of the scales

  3. Quality of life (physical function, emotional role, social function, cognitive function and symptoms such a fatigue, anorexia, dyspnea, etc) [At 6 months after the start of the intervention]

    Questionnaire of EORT-QLQ-29 values are assigned between 1 and 4 (1: not at all, 2: a little, 3: quite a bit, 4: a lot) according to the patient's responses to the item, only items 29 and 30 are evaluated with a score of 1 to 7 (1: lousy, 7: excellent). The scores obtained are standardized and a score between 0 and 100 is obtained, which determines the level of impact of the cancer on the patient on each of the scales

  4. Quality of life (physical function, emotional role, social function, cognitive function and symptoms such a fatigue, anorexia, dyspnea, etc) [One year after the start of the intervention]

    Questionnaire of EORT-QLQ-29 values are assigned between 1 and 4 (1: not at all, 2: a little, 3: quite a bit, 4: a lot) according to the patient's responses to the item, only items 29 and 30 are evaluated with a score of 1 to 7 (1: lousy, 7: excellent). The scores obtained are standardized and a score between 0 and 100 is obtained, which determines the level of impact of the cancer on the patient on each of the scales

  5. Motivation in exercise context [Pre intervention]

    Questionnaire BREQ-3 (from 1 to 4 points, being from less autonomous types of motivation to more autonomous types of motivation, based on Self-Determination Theory)

  6. Motivation in exercise context [In the middle of the intervention (at 3 months)]

    Questionnaire BREQ-3 (from 1 to 4 points, being from less autonomous types of motivation to more autonomous types of motivation, based on Self-Determination Theory)

  7. Motivation in exercise context [At 6 months after the start of the intervention]

    Questionnaire BREQ-3 (from 1 to 4 points, being from less autonomous types of motivation to more autonomous types of motivation, based on Self-Determination Theory)

  8. Motivation in exercise context [One year after the start of the intervention]

    Questionnaire BREQ-3 (from 1 to 4 points, being from less autonomous types of motivation to more autonomous types of motivation, based on Self-Determination Theory)

  9. Body composition [Pre intervention]

    waist and hip circumference/ waist and hip index

  10. Body composition [In the middle of the intervention (at 3 months)]

    waist and hip circumference/ waist and hip index

  11. Body composition [At 6 months after the start of the intervention]

    waist and hip circumference/ waist and hip index

  12. Body composition [One year after the start of the intervention]

    waist and hip circumference/ waist and hip index

  13. Autonomy support questionnaire [Pre intervention]

    Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES). From 1 to 7 points, being more score, more perceived support

  14. Autonomy support questionnaire [In the middle of intervention (at 3 months)]

    Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES)Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES). From 1 to 7 points, being more score, more perceived support

  15. Autonomy support questionnaire [At 6 months after the start of the intervention]

    Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES)Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES). From 1 to 7 points, being more score, more perceived support

  16. Autonomy support questionnaire [One year after the start of the intervention]

    Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES)Support Scale for Perceived Autonomy in Physical Exercise Contexts (PASSES). From 1 to 7 points, being more score, more perceived support

  17. Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS) [Pre intervention]

    In general life context (from 1 to 5 points)

  18. Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS) [In the middle of intervention (at 3 months)]

    In general life context (from 1 to 5 points)

  19. Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS) [At 6 months after the start of the intervention]

    In general life context (from 1 to 5 points)

  20. Basic Psychological Needs Satisfaction and Frustration Scale (BPNSFS) [One year after the start of the intervention]

    In general life context (from 1 to 5 points)

  21. The scale of Basic Psychological Needs in Exercise (BPNES) will be used [Pre intervention]

    In exercise context (from 1 to 5 points, being more score, more satisfaction of basic psychological needs)

  22. The scale of Basic Psychological Needs in Exercise (BPNES) will be used [In the middle of intervention (at 3 months)]

    (from 1 to 5 points, being more score, more satisfaction of basic psychological needs)

  23. The scale of Basic Psychological Needs in Exercise (BPNES) will be used [At 6 months after the start of the intervention]

    (from 1 to 5 points, being more score, more satisfaction of basic psychological needs)

  24. The scale of Basic Psychological Needs in Exercise (BPNES) will be used [One year after the start of the intervention]

    (from 1 to 5 points, being more score, more satisfaction of basic psychological needs)

  25. Perceived barriers to physical activity participation questionnaire [Pre intervention]

    On this scale, patients are asked how often different barriers (time, pain, cost, fatigue, etc.) have interfered with their participation in physical exercise during cancer treatment.

  26. Perceived barriers to physical activity participation questionnaire [In the middle of intervention (at 3 months)]

    On this scale, patients are asked how often different barriers (time, pain, cost, fatigue, etc.) have interfered with their participation in physical exercise during cancer treatment.

  27. Perceived barriers to physical activity participation questionnaire [At 6 months after the start of the intervention]

    On this scale, patients are asked how often different barriers (time, pain, cost, fatigue, etc.) have interfered with their participation in physical exercise during cancer treatment.

  28. Perceived barriers to physical activity participation questionnaire [One year after the start of the intervention]

    On this scale, patients are asked how often different barriers (time, pain, cost, fatigue, etc.) have interfered with their participation in physical exercise during cancer treatment.

  29. Hope State Questionnaire [Pre intervention]

    Scale of hope state to face the disease

  30. Hope State Questionnaire [In the middle of intervention (at 3 months)]

    Scale of hope state to face the disease

  31. Hope State Questionnaire [At 6 months after the start of the intervention]

    Scale of hope state to face the disease

  32. Hope State Questionnaire [One year after the start of the intervention]

    Scale of hope state to face the disease

  33. Physical condition questionnaire [Pre intervention]

    International Fitness Scale (IFI)

  34. Physical condition questionnaire [In the middle of intervention (at 3 months)]

    International Fitness Scale (IFI)

  35. Physical condition questionnaire [At 6 months after the start of the intervention]

    International Fitness Scale (IFI)

  36. Physical condition questionnaire [One year after the start of the intervention]

    International Fitness Scale (IFI)

  37. Side effects of the chemotherapy [Pre intervention]

    Fatigue questionnaire FACIT

  38. Side effects of the chemotherapy [In the middle of intervention (at 3 months)]

    Fatigue questionnaire FACIT

  39. Side effects of the chemotherapy [At 6 months after the start of the intervention]

    Fatigue questionnaire FACIT

  40. Side effects of the chemotherapy [One year after the start of the intervention]

    Fatigue questionnaire FACIT

  41. Physical activity levels (subjective) [Pre intervention]

    International physical activity questionnaire (IPAQ)

  42. Physical activity levels (subjective) [In the middle of intervention (at 3 months)]

    International physical activity questionnaire (IPAQ)

  43. Physical activity levels (subjective) [At 6 months after the start of the intervention]

    International physical activity questionnaire (IPAQ)

  44. Physical activity levels (subjective) [One year after the start of the intervention]

    International physical activity questionnaire (IPAQ)

  45. Physical activity levels (objective) [Pre intervention]

    Accelerometer

  46. Physical activity levels (objective) [In the middle of intervention (at 3 months)]

    Accelerometer

  47. Physical activity levels (objective) [At 6 months after the start of the intervention]

    Accelerometer

  48. Physical activity levels (objective) [One year after the start of the intervention]

    Accelerometer

  49. Depression and anxiety [Pre intervention]

    The Hospital Anxiety and Depression Scale questionnaire (1-4 scale: never, not very often, sometimes, slmost always, the higher the score worse the result)

  50. Depression and anxiety [In the middle of intervention (at 3 months)]

    The Hospital Anxiety and Depression Scale questionnaire (1-4 scale: never, not very often, sometimes, slmost always, the higher the score worse the result)

  51. Depression and anxiety [At 6 months after the start of the intervention]

    The Hospital Anxiety and Depression Scale questionnaire (1-4 scale: never, not very often, sometimes, slmost always, the higher the score worse the result)

  52. Depression and anxiety [One year after the start of the intervention]

    The Hospital Anxiety and Depression Scale questionnaire (1-4 scale: never, not very often, sometimes, slmost always, the higher the score worse the result)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Being more than 18 years

  • Colorectal cancer stage II and III

  • Be receiving adjuvant chemotherapy treatment after surgery

  • Ecog > 1

  • No medical contraindications

Exclusion criteria:
  • Have a disability

  • Colorectal cancer stage IV

  • Presence of metastasis

  • Ecog < 1

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universidad Miguel Hernández Elche Elche/Alicante Spain 03202
2 Hospital Universitario Puerta de Hierro Madrid Majadahonda/Madrid Spain 28222

Sponsors and Collaborators

  • Universidad Miguel Hernandez de Elche
  • Puerta de Hierro University Hospital
  • Ministerio de Ciencia e Innovación, Spain

Investigators

  • Principal Investigator: David González-Cutre Coll, PhD, Miguel Hernández University of Elche

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David González-Cutre Coll, Senior Lecturer, Universidad Miguel Hernandez de Elche
ClinicalTrials.gov Identifier:
NCT04506840
Other Study ID Numbers:
  • DPS.DGC.01.19
First Posted:
Aug 10, 2020
Last Update Posted:
Sep 29, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by David González-Cutre Coll, Senior Lecturer, Universidad Miguel Hernandez de Elche
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2021